Trump Fast-Tracks Psychedelic Medical Research

In a significant policy shift, President Trump signed an executive order intended to accelerate access to medical research and treatments involving psychedelic drugs.

The President was joined in the Oval Office by podcaster Joe Rogan and Health Secretary Robert F. Kennedy Jr., both of whom have publicly championed the therapeutic potential of these substances.

While drugs like ibogaine remain in the most restrictive federal legal category, the order calls for a relaxation of research barriers to aid veterans suffering from debilitating psychological conditions.

This move marks a major step toward the mainstreaming of psychedelic medicine in the United States.